The most important financial indicators for the company Syncro Clinical Research Srl - Unique Identification Number 18281936:
sales in 2023 was
67.117
euro, registering a net profit of
18.990
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -39.5%, from 111.337 euro in the year 2022, to 67.117 euro in 2023.
The Net Profit decreased by -39.188 euro, from 58.355 euro in 2022, to 18.990 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Syncro Clinical Research Srl - CUI 18281936
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
121.675
134.818
27.540
18.589
12.554
3.249
1.757
230.413
266.094
254.205
Current Assets
47.769
59.364
63.967
49.125
68.577
36.179
49.132
26.674
31.924
21.670
Inventories
0
0
0
0
15.254
0
0
0
223
0
Receivables
37.946
45.758
22.364
25.413
0
15.444
20.496
20.797
24.135
17.429
Cash
9.823
13.606
41.603
23.712
53.323
20.735
28.636
5.878
7.566
4.241
Shareholders Funds
140.304
150.681
69.437
65.911
40.173
29.774
49.827
109.009
167.703
186.184
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
30.016
44.229
22.070
1.804
40.957
9.654
1.062
148.078
130.316
89.691
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
21.670 euro in 2023 which includes Inventories of
0 euro, Receivables of
17.429 euro and cash availability of
4.241 euro.
The company's Equity was valued at
186.184 euro, while total Liabilities amounted to
89.691 euro.
Equity increased by 18.990 euro, from 167.703 euro in 2022, to 186.184 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Syncro Clinical Research Srl